Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
CSE: ALEN.U — AI Meets Digital Health (click to learn more) What’s Behind Cannabis Stock HERB? (click to learn more) Eshbal Acquires a 55% Interest in Dare to Be Different Foods (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Zenith Capital Corporation (EM) ZHCLF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company’s lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration with Astellas and Newsoara, as well as advanced or... see more

Current News (EXPM:ZHCLF)

No current news is available.
View More News ››

Opinion & Analysis (EXPM:ZHCLF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:ZHCLF)

Zenith Epigenetics gets Fast Track approval with 3694!!

Interesting play for sure,,,,,,I bught some,,,and I see a new PP done lately,,, Date: December 11, 2025  Promissory Note, ...
narmac - December 22, 2025

RE:WTF r u doing Don?

I'm seeing ZHCLF closed at .20 on Friday 1/29.  As a Canadian you can buy the stock. grab some next time at .0001 is my advice
Temsamany - October 29, 2022
View more Bullboard ››

SEGO Resources Inc.

SEGO Resources Inc.

Sego Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral ...
View More »

Podcasts